BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25640750)

  • 1. Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2015 Sep; 67(3):331-7. PubMed ID: 25640750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assignment of primary site in high-grade serous tubal, ovarian and peritoneal carcinoma: a proposal.
    Singh N; Gilks CB; Wilkinson N; McCluggage WG
    Histopathology; 2014 Aug; 65(2):149-54. PubMed ID: 24660659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging findings of extrauterine high-grade serous carcinoma based on new pathologic criteria for primary site assignment.
    Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Miyazaki T; Matsuo M
    Acta Radiol; 2021 May; 62(5):687-694. PubMed ID: 32576024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians.
    McCluggage WG; Hirschowitz L; Gilks CB; Wilkinson N; Singh N
    Int J Gynecol Pathol; 2017 May; 36(3):230-239. PubMed ID: 27801755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E; Leitao MM; Soslow RA
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic study of serous tubal intraepithelial carcinoma with invasive carcinoma: is serous tubal intraepithelial carcinoma a reliable feature for determining the organ of origin?
    Gao FF; Bhargava R; Yang H; Li Z; Zhao C
    Hum Pathol; 2013 Aug; 44(8):1534-43. PubMed ID: 23465279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Singh N; Benson JL; Gan C; Anglesio M; Arora R; Faruqi AZ; Hirschowitz L; Kommoss F; Scott K; Trevisan G; Leen SLS; Wilkinson N; Gilks CB; McCluggage WG
    Int J Gynecol Pathol; 2018 Jul; 37(4):324-330. PubMed ID: 28787323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer.
    Seidman JD; Zhao P; Yemelyanova A
    Gynecol Oncol; 2011 Mar; 120(3):470-3. PubMed ID: 21159368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.
    Saida T; Tanaka YO; Matsumoto K; Satoh T; Yoshikawa H; Minami M
    Jpn J Radiol; 2016 Feb; 34(2):117-24. PubMed ID: 26696400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the fallopian tubes after neoadjuvant chemotherapy: persistence of serous tubal intraepithelial carcinoma.
    Colón E; Carlson JW
    Int J Gynecol Pathol; 2014 Sep; 33(5):463-9. PubMed ID: 25083961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
    Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
    Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
    Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
    Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.
    Ducie J; Dao F; Considine M; Olvera N; Shaw PA; Kurman RJ; Shih IM; Soslow RA; Cope L; Levine DA
    Nat Commun; 2017 Oct; 8(1):990. PubMed ID: 29042553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.